Xenon Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.

About XENE

Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. 

CEO
Ian C. Mortimer
CEOIan C. Mortimer
Employees
370
Employees370
Headquarters
Burnaby, British Columbia
HeadquartersBurnaby, British Columbia
Founded
1996
Founded1996
Employees
370
Employees370

XENE Key Statistics

Market cap
3.73B
Market cap3.73B
Price-Earnings ratio
-7.93
Price-Earnings ratio-7.93
Dividend yield
—
Dividend yield—
Average volume
1.31M
Average volume1.31M
High today
$38.99
High today$38.99
Low today
$37.25
Low today$37.25
Open price
$38.04
Open price$38.04
Volume
377.41K
Volume377.41K
52 Week high
$72.66
52 Week high$72.66
52 Week low
$33.38
52 Week low$33.38

Stock Snapshot

With a market cap of 3.73B, Xenon Pharmaceuticals(XENE) trades at $38.52. The stock has a price-to-earnings ratio of -7.93.

As of 2026-11-03, Xenon Pharmaceuticals(XENE) stock has fluctuated between $37.25 and $38.99. The current price stands at $38.52, placing the stock +3.4% above today's low and -1.2% off the high.

The Xenon Pharmaceuticals(XENE)'s current trading volume is 377.41K, compared to an average daily volume of 1.31M.

During the past year, Xenon Pharmaceuticals(XENE) stock moved between $33.38 at its lowest and $72.66 at its peak.

During the past year, Xenon Pharmaceuticals(XENE) stock moved between $33.38 at its lowest and $72.66 at its peak.

XENE News

Simply Wall St 2d
Learn Why The Bull Case For Xenon Pharmaceuticals Stock Could Change Following Pain Trial Progress - Simply Wall St

...

Learn Why The Bull Case For Xenon Pharmaceuticals Stock Could Change Following Pain Trial Progress - Simply Wall St

Analyst ratings

94%

of 18 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

People also own

Based on the portfolios of people who own XENE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.